Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR8.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR7.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR9.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR6.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR3.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR2.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR4.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR1.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR5.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR25.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR17.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR26.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR45.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR39.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR29.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR10.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR41.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR32.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR22.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR44.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR30.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR15.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR42.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR23.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR28.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR18.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR12.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR27.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR19.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR11.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR38.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR43.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR40.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR36.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR21.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR37.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR34.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR31.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR13.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR24.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR14.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR33.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR16.htm
EX-32.1 - CERTIFICATION - MEDICAL INTERNATIONAL TECHNOLOGY INCf10k2012ex32i_medicalint.htm
10-K - ANNUAL REPORT - MEDICAL INTERNATIONAL TECHNOLOGY INCf10k2012_medicalint.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR35.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR20.htm
 
EXHIBIT 31.1
CERTIFICATION
OF PRINCIAPL EXECUTIVE OFFICER AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Karim Menassa, certify that:

1.
I have reviewed this Form 10-K of Medical International Technology, Inc.;
   
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
   
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
   
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
   
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
(d)
 Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
(b)
Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: December 28, 2012
 
/s/ Karim Menassa
Karim Menassa
President and Chief Executive Officer,
Chief Financial Officer, interim Secretary
(Principal Executive and Principal Financial Officer)